SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 128 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q4 2015. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $9,000 | -93.7% | 78,824 | -6.1% | 0.00% | – |
| Q3 2018 | $143,000 | +11.7% | 83,940 | +14.5% | 0.00% | – |
| Q2 2018 | $128,000 | -5.2% | 73,304 | -0.2% | 0.00% | – |
| Q1 2018 | $135,000 | -15.6% | 73,453 | +2.1% | 0.00% | – |
| Q4 2017 | $160,000 | +56.9% | 71,964 | +104.5% | 0.00% | – |
| Q3 2017 | $102,000 | -44.9% | 35,189 | -15.2% | 0.00% | – |
| Q2 2017 | $185,000 | +6.3% | 41,507 | +11.2% | 0.00% | – |
| Q1 2017 | $174,000 | -13.4% | 37,343 | +12.9% | 0.00% | – |
| Q4 2016 | $201,000 | +12.3% | 33,076 | +2.0% | 0.00% | – |
| Q3 2016 | $179,000 | +47.9% | 32,427 | +1.6% | 0.00% | – |
| Q2 2016 | $121,000 | +152.1% | 31,927 | +82.4% | 0.00% | – |
| Q1 2016 | $48,000 | -50.0% | 17,505 | +3.4% | 0.00% | – |
| Q4 2015 | $96,000 | +6.7% | 16,927 | 0.0% | 0.00% | – |
| Q3 2015 | $90,000 | -28.0% | 16,927 | +12.0% | 0.00% | – |
| Q2 2015 | $125,000 | – | 15,114 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nantahala Capital Management | 11,578,568 | $20,147,000 | 0.82% |
| Virtus ETF Advisers LLC | 441,461 | $768,000 | 0.68% |
| Hikari Power Ltd | 2,300,000 | $4,002,000 | 0.44% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,403,149 | $2,441,000 | 0.17% |
| KNOTT DAVID M | 225,400 | $392,000 | 0.15% |
| Clear Harbor Asset Management, LLC | 277,110 | $482,000 | 0.09% |
| Malaga Cove Capital, LLC | 97,264 | $169,000 | 0.09% |
| Lehman Financial Resources, Inc. | 80,800 | $140,000 | 0.07% |
| Cheyne Capital Management (UK) LLP | 50,000 | $87,000 | 0.06% |
| Ballew Advisors, Inc | 26,200 | $46,000 | 0.05% |